Difference between revisions of "Part:BBa K3096030:Design"

m (References)
m (Source)
Line 13: Line 13:
 
===Source===
 
===Source===
  
https://www.ncbi.nlm.nih.gov/nuccore/DI220025.1
+
KR 1020120130606-A/1: Secretion signal peptide linked Exendin-4 gene transduced pancreatic islet cluster for treatment of type I diabetes
  
 
===References===
 
===References===
 
Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006
 
Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006

Revision as of 12:41, 15 October 2019


Exendin-4 (GLP-1 analogue) with secretion signal


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

no changes were made to the sequence


Source

KR 1020120130606-A/1: Secretion signal peptide linked Exendin-4 gene transduced pancreatic islet cluster for treatment of type I diabetes

References

Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439. https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006